Engineered Microbial Pathways for Syngas Conversion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing isopropanol, 4-hydroxybutyrate, and 1,4-butanediol from carbohydrates, methanol, and syngas are limited by the inefficiency and cost of existing petrochemical routes, and the poor characterization and genetic manipulability of organisms like Clostridium, which restricts commercialization and product yield.
Innovation Solution
Development of non-naturally occurring microbial organisms with engineered pathways that include specific enzymes such as succinyl-CoA:3-ketoacid-CoA transferase for isopropanol production, and enzymes like acetoacetyl-CoA thiolase and 4-hydroxybutyryl-CoA reductase for 4-hydroxybutyrate and 1,4-butanediol production, enabling efficient conversion of carbohydrates, methanol, and syngas into these chemicals.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If petrochemical routes are used for producing isopropanol, 4-hydroxybutyrate, and 1,4-butanediol, then production capacity is maintained, but production costs increase and feedstock flexibility is limited
Solution Approach 1:
The patent changes the fundamental parameter of feedstock type from petrochemical sources to renewable biomass and syngas, combined with changing the production method from chemical catalysis to biological fermentation. This dual parameter change achieves both cost reduction through cheaper feedstocks and maintains productivity through optimized microbial pathways and fermentation processes.
2Adaptability or versatility
If Clostridium organisms are used for conversion, then syngas utilization is achieved, but genetic manipulability is poor and commercialization is restricted
Solution Approach 1:
The patent segments the metabolic pathway into distinct modular components that can be independently engineered and optimized. By dividing the complex conversion process into separate enzymatic steps and pathway segments, the system achieves both syngas utilization capability and improved genetic manipulability through targeted genetic modifications in each segment.
Solution Approach 2:
The patent introduces intermediary metabolic pathways and intermediate compounds that bridge syngas conversion and final product formation. These intermediary steps serve as controllable checkpoints that improve genetic manipulability by providing multiple targets for genetic engineering while maintaining the overall syngas utilization capability.
3Reliability
If existing microbial pathways are used, then natural conversion occurs, but product yield is low and efficiency is poor
Solution Approach 1:
The patent applies preliminary genetic engineering actions to optimize metabolic pathways before industrial-scale production. By pre-engineering the microbial organisms with enhanced pathway efficiency, optimized enzyme expression, and improved metabolic flux distribution, the system achieves both reliable natural conversion capability and high product yield through preparatory genetic modifications.
Solution Approach 2:
The patent creates composite metabolic pathways by combining multiple enzymatic activities and pathway elements within a single organism. This composite approach integrates syngas conversion pathways with product formation pathways, achieving both reliable conversion and enhanced productivity through synergistic pathway integration.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These engineered organisms achieve higher yields and operational flexibility, reducing production costs and enabling the use of diverse feedstocks, thus addressing the limitations of traditional methods and enhancing sustainability.
Implementation Method 1
engineered pathways that include specific enzymes such as succinyl-CoA:3-ketoacid-CoA transferase for isopropanol production, and enzymes like acetoacetyl-CoA thiolase and 4-hydroxybutyryl-CoA reductase for 4-hydroxybutyrate and 1,4-butanediol production
Data Source
AI summary
A non-naturally occurring microbial organism having an isopropanol, 4-hydroxybutryate, or 1,4-butanediol pathway includes at least one exogenous nucleic acid encoding an isopropanol, 4-hydroxybutryate, or 1,4-butanediol pathway enzyme expressed in a sufficient amount to produce isopropanol, 4-hydroxybutryate, or 1,4-butanediol. The aforementioned organisms are cultured to produce isopropanol, 4-hydroxybutryate, or 1,4-butanediol.